Linger Liu

602 total citations · 1 hit paper
5 papers, 469 citations indexed

About

Linger Liu is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Linger Liu has authored 5 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 3 papers in Oncology and 1 paper in Molecular Biology. Recurrent topics in Linger Liu's work include Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Head and Neck Cancer Studies (1 paper) and Pancreatic and Hepatic Oncology Research (1 paper). Linger Liu is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Head and Neck Cancer Studies (1 paper) and Pancreatic and Hepatic Oncology Research (1 paper). Linger Liu collaborates with scholars based in China. Linger Liu's co-authors include Xiaona Cai, Congying Xie, Xiance Jin, Huafang Su, Lihao Zhao, Baochai Lin, Didi Chen, Lanxiao Shen, Hanbin Chen and Shaoran Fei and has published in prestigious journals such as Clinical Cancer Research, Anti-Cancer Drugs and Radiation Oncology.

In The Last Decade

Linger Liu

4 papers receiving 467 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non–Small Cell Lung Cancer Using Next-Generation Sequencing

2017 437 citations Xiance Jin, Yanfan Chen et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Linger Liu China	3	388	364	59	45	37	5	469
Huanle Pan China	7	606 1.6×	531 1.5×	67 1.1×	63 1.4×	41 1.1×	10	698
Theresa Heider Germany	8	287 0.7×	193 0.5×	23 0.4×	30 0.7×	44 1.2×	12	346
Shaoran Fei China	5	390 1.0×	363 1.0×	90 1.5×	53 1.2×	38 1.0×	5	486
Rogelio Montiel-Manríquez Mexico	5	365 0.9×	321 0.9×	58 1.0×	30 0.7×	30 0.8×	8	461
Lisa Mutschelknaus Germany	7	335 0.9×	222 0.6×	24 0.4×	33 0.7×	54 1.5×	7	375
Rhafaela Lima Causin Brazil	9	151 0.4×	150 0.4×	24 0.4×	68 1.5×	16 0.4×	13	249
С. А. Тузиков Russia	9	163 0.4×	123 0.3×	95 1.6×	58 1.3×	28 0.8×	52	289
Yong Hyun Park South Korea	11	244 0.6×	178 0.5×	108 1.8×	37 0.8×	25 0.7×	18	373
Torveig Weum Abrahamsen Norway	7	241 0.6×	151 0.4×	39 0.7×	60 1.3×	12 0.3×	13	328

Countries citing papers authored by Linger Liu

Since Specialization

Citations

This map shows the geographic impact of Linger Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linger Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linger Liu more than expected).

Fields of papers citing papers by Linger Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linger Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linger Liu. The network helps show where Linger Liu may publish in the future.

Co-authorship network of co-authors of Linger Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Linger Liu. A scholar is included among the top collaborators of Linger Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linger Liu. Linger Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Liu, Linger, et al.. (2024). Combination of anlotinib and toripalimab for an advanced biliary tract cancer patient with high Eastern Cooperative Oncology Group performance status: a case report. Anti-Cancer Drugs. 35(8). 752–756.

2.

Liu, Linger, et al.. (2023). HER2-positive advanced biliary tract cancer responds to second-line pyrotinib therapy: a case report. Anti-Cancer Drugs. 35(3). 298–301. 2 indexed citations

3.

Liu, Linger, Lihao Zhao, Huafang Su, et al.. (2018). Induction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus volumetric modulated arc therapy alone in the treatment of stage II-IVB nasopharyngeal carcinoma patients: a retrospective controlled study. Radiation Oncology. 13(1). 148–148. 22 indexed citations

4.

Cai, Xiaona, Dian-na Gu, Linger Liu, et al.. (2018). The effect of the primary tumor location on the survival of colorectal cancer patients after radical surgery. International Journal of Medical Sciences. 15(14). 1640–1647. 8 indexed citations

5.

Jin, Xiance, Yanfan Chen, Hanbin Chen, et al.. (2017). Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non–Small Cell Lung Cancer Using Next-Generation Sequencing. Clinical Cancer Research. 23(17). 5311–5319. 437 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact